Skip to main content

Table 1 Incidence of pathogens isolated from ICU patients by country (%)

From: Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

United States

Canada

Italy

Germany

France

Organism

Incidence (%)

Organism

Incidence (%)

Organism

Incidence (%)

Organism

Incidence (%)

Organism

Incidence (%)

S. aureus a

20.2

S. aureus a

17.4

P. aeruginosa

22.3

CNS

16.4

S. aureus 1

17.2

CNSb

15.9

CNS

16.1

CNS

18.7

S. aureus a

13.6

CNS

16.7

P. aeruginosa

13.1

E. coli

12.6

S. aureus a

18.1

E. coli

12.3

E. coli

15.5

E. coli

9.2

P. aeruginosa

11.3

E. coli

7.7

P. aeruginosa

10.8

P. aeruginosa

13.8

K. pneumoniae

5.8

Enterococcus spp

7.6

E. faecalis

3.9

Enterococcus spp

7.4

S. pneumoniae

3.3

Enterococcus spp

5.4

K. pneumoniae

5.5

K. pneumoniae

3.5

K. pneumoniae

5.4

E. cloacae

3.3

E. cloacae

4.3

E. cloacae

4.2

Enterococcus spp

3.3

E. cloacae

4.7

E. faecalis

3.0

E. faecalis

3.7

S. marcenscens

2.5

E. cloacae

2.6

E. faecalis

4.3

K. pneumoniae

2.7

S. marcescens

2.7

H. influenzae

2.1

S. marcescens

2.2

P. mirabilis

2.6

P. mirabilis

2.5

A. baumanii

2.6

E. faecalis

2.1

P. mirabilis

1.9

K. oxytoca

2.4

Enterococcus spp

2.3

Enterobacteriaceaec (all species combined)

29.5

Enterobacteriaceae (all species combined)

33.0

Enterobacteriaceae (all species combined)

30.2

Enterobacteriaceae (all species combined)

36.0

Enterobacteriaceae (all species combined)

32.1

Total (n)

26,624

Total (n)

54,445

Total (n)

34,609

Total (n)

48,385

Total (n)

62,459

  1. aProportion of S. aureus testing as MRSA was USA (52.3%), Canada (19.7%), Italy (59.4%), Germany (21.0%), and France (40.6%) bCNS = Coagulase-negative staphylococci cEnterobacteriaceae includes all species of genera occurring at >0.1%